- Open Access
Expression of early transcription factors Oct-4, Sox-2 and Nanog by porcine umbilical cord (PUC) matrix cells
© Carlin et al; licensee BioMed Central Ltd. 2006
Received: 18 November 2005
Accepted: 06 February 2006
Published: 06 February 2006
Three transcription factors that are expressed at high levels in embryonic stem cells (ESCs) are Nanog, Oct-4 and Sox-2. These transcription factors regulate the expression of other genes during development and are found at high levels in the pluripotent cells of the inner cell mass. The downregulation of these three transcription factors correlates with the loss of pluripotency and self-renewal, and the beginning of subsequent differentiation steps. The roles of Nanog, Oct-4 and Sox-2 have not been fully elucidated. They are important in embryonic development and maintenance of pluripotency in ESCs. We studied the expression of these transcription factors in porcine umbilical cord (PUC) matrix cells.
Cells were isolated from Wharton's jelly of porcine umbilical cords (PUC) and histochemically assayed for the presence of alkaline phosphatase and the presence of Nanog, Oct-4 and Sox-2 mRNA and protein. PCR amplicons were sequenced and compared with known sequences. The synthesis of Oct-4 and Nanog protein was analyzed using immunocytochemistry. FACS analysis was utilized to evaluate Hoechst 33342 dye-stained cells.
PUC isolates were maintained in culture and formed colonies that express alkaline phosphatase. FACS analysis revealed a side population of Hoechst dye-excluding cells, the Hoechst exclusion was verapamil sensitive. Quantitative and non-quantitative RT-PCR reactions revealed expression of Nanog, Oct-4 and Sox-2 in day 15 embryonic discs, PUC cell isolates and porcine fibroblasts. Immunocytochemical analysis detected Nanog immunoreactivity in PUC cell nuclei, and faint labeling in fibroblasts. Oct-4 immunoreactivity was detected in the nuclei of some PUC cells, but not in fibroblasts.
Cells isolated from PUC express three transcription factors found in pluripotent stem cell markers both at the mRNA and protein level. The presence of these transcription factors, along with the other characteristics of PUC cells such as their colony-forming ability, Hoechst dye-excluding side population and alkaline phosphatase expression, suggests that PUC cells have properties of primitive pluripotent stem cells. Furthermore, PUC cells are an easily and inexpensively obtained source of stem cells that are not hampered by the ethical or legal issues associated with ESCs. In addition, these cells can be cryogenically stored and expanded.
Stem cells constitute a population of cells that are present in all stages of development from preimplantation embryos through adulthood. Pluripotent stem cells have the ability to self-renew for indefinite periods in culture and to differentiate, e.g., give rise to all of the specialized cells in an animal. Currently, pluripotent stem cells can be isolated consistently only from the inner cell mass of embryos or from the gonadal ridge . In contrast, multipotent stem cells have the ability to self-renew and to differentiate into two of the three germ layers; this type of cell has been isolated from adult animals . It would be advantageous to have a readily available, low cost source of stem cells in large animal species to facilitate biotechnology, since embryonic stem cells (ESCs) are problematic.
Three transcription factors found in mouse and human ESCs play a central role in the regulation of pluripotency and self-renewal. These factors include the POU (Pit/Oct/Unc) domain-containing protein Oct-4 [3–5], Sox-2  and the homeoprotein Nanog [7, 8]. All three transcription factors are expressed in high levels in pluripotent cells and are considered markers of primitive stem cells. The conservation of these three transcription factors across mammalian species is becoming apparent. A recent report suggests that they work in a cooperative fashion to regulate many genes .
ESCs, derived from the inner cell mass, and primordial or embryonic germ cells (EGCs), derived from the gonadal ridge, are two examples of pluripotent stem cells. Stem cells with more restricted differentiation potential have been isolated from most postnatal tissues. Postnatal sources of stem cells include bone marrow , umbilical cord blood [11–13], vasculature or perivascular space [14–16], placental tissue [17, 18] amniotic fluid , adipose tissue  and skin . In general, Oct-4, Sox-2 and Nanog are not highly expressed in these stem cells and they are not thought to be pluripotent. While stem cells from these sources are not pluripotent or immortal, technical considerations such as ease of collection, collection of a large number of cells, collection for autologous transplantation, and ethical considerations such as collection with informed consent, are important counterpoints. For stem cell applications in biotechnology and agriculture, the ability to collect large number of cells, the collection of cells inexpensively and non-invasively, without risk to the donor, and the ability to cryogenically bank and expand the cells in vitro are important considerations. Therapeutically, stem cells from non-embryonic sources have been used clinically and have successfully treated a number of diseases. To advance animal biotechnology, it will be necessary to produce ESCs and EGCs that display germ line transmission in species other than the mouse; so far this has not met with success .
The stem cell population in Wharton's jelly of the umbilical cord has properties that make it of interest [23–26]. For example, it is simple to harvest by non-invasive means, provides large numbers of cells without risk to the donor, the stem cell population may be expanded in vitro, cryogenically stored, thawed, expanded, genetically manipulated and differentiated in vitro . The umbilical cord forms early during gestation, and it encloses the yolk sac, which is the embryologic source of both primordial germ cells and the first hematopoietic stem cells. Importantly, the umbilical cord's physiological functions end at parturition. This structure is embryonic in origin and harvested after birth. The umbilical cord Wharton's Jelly and the umbilical cord blood are non-controversial sources of primitive stem cells that can be collected and stored after birth for therapeutic uses or biotechnology.
Here, we characterize umbilical cord Wharton's Jelly stem cells (called umbilical cord matrix cells) collected from pig. The pig is a useful target for stem cell technology for biomedical models for humans  and for agricultural applications. Previously, we showed that after exposure to differentiation signals, cells derived from human or porcine umbilical cord matrix are capable of expressing the morphology and markers of neural cells, and the undifferentiated cells express a variety of characteristics indicative of stem cells, for example, telomerase . Here, we extend that characterization by examining the expression of the transcription factors Nanog, Oct-4 and Sox-2. These factors are of central importance to pluripotency and self-renewal in mouse and human embryonic stem cells [3–8]. In addition, several other characteristics of stem cells are evaluated.
Materials and methods
Umbilical cord acquisition and cell procurement
All experimental protocols were approved by the Kansas State University Institutional Care and Use Committee (IACUC #2164). Umbilical cords were collected from newborn (term) or mid-gestation (50–55 days post-conception), male and female pigs obtained from the Kansas State University swine farm. Term umbilical cords were collected immediately after birth and placed in sterile 0.9% saline or Ringer solution (composition in mM: 120 NaCl 25 NaHCO3, 3.3 KH2PO4, 0.83 K2HPO4, 1.2 CaCl2 and 1.2 MgCl2) and transported to the laboratory at room temperature. Mid-gestation fetuses and day 14–15 postestrus embryonic discs were collected from sows under general anesthesia using standard veterinary procedures. Once in the laboratory, the cords were rinsed in sterile phosphate buffered saline (PBS, composition in mM: 140 NaCl; 2 KCl; 1.5 KH2PO4; 15 Na2HPO4), supplemented with 4 μg/ml amphotericin B, 20 μg/ml gentamicin, 100 U/ml penicillin, and 100 μg/ml streptomycin and placed in a sterile petri dish for further processing. Umbilical cord segments 1–3 cm in length were cut longitudinally to expose the two umbilical arteries and the umbilical vein. The vessels were removed and discarded. The remaining umbilical cord tissue including the Wharton's jelly was diced into 2–5 mm3 explants using single edge razor blades, transferred to 6-well tissue culture plates (Corning Inc., Corning, NY) containing 2 ml of cell culture medium (56% DMEM (low glucose, Gibco-Invitrogen Corporation, Carlsbad, CA), 37% MCDB 201 (Sigma-Aldrich, Inc., St. Louis, MO), 2% fetal bovine serum (FBS, Atlanta Biologicals, Lawrenceville, GA); remaining 5%: 1× insulin-transferrin-selenium supplement (ITS, Sigma-Aldrich, Inc.), 1.5 mg/ml AlbuMax I (Gibco-Invitrogen Corp.), 1 nM dexamethasone (Sigma-Aldrich), 100 μM ascorbic acid 2-phosphate (Sigma-Aldrich, Inc.), 100 U/ml penicillin, 100 μg/ml streptomycin, 0.25 μg/ml amphotericin B (Gibco-Invitrogen), 10 ng/ml recombinant human epidermal growth factor (EGF, R&D Systems, Minneapolis, MN), 10 ng/ml rat platelet-derived growth factor (PDGF, R&D Systems)) and maintained in a 37°C incubator with a 5% CO2 atmosphere and saturated humidity. Adherent porcine umbilical cord (PUC) cells were observed 24–48 hrs after plating. Tissue explants were removed from culture and the remaining adhered PUC cells were dissociated with 0.1% trypsin + 1.0 mM EDTA in PBS (trypsin/EDTA, Gibco-Invitrogen) for 3 min. Cells that had detached in this time were subcultured to a new flask at a ratio of 1:5 (denoted passage 1) and the remaining cells were discarded. From this preparation PUC cells were maintained in culture and periodically subcultured, seeded onto coverslips for immunocytochemical analysis, or processed for RNA isolation. For long-term storage, PUC cells were also cryopreserved in a freezing medium consisting of 93% FBS and 7% dimethyl sulfoxide (DMSO, Sigma-Aldrich, Inc.). Early results of the experiments described here from frozen and fresh cells were indistinguishable. Thus, no distinction was made between freshly isolated or frozen PUC cells. Furthermore, no comparisons between PUC cell isolates derived from the two sexes or isolates derived from term or mid-gestation umbilical cord were conducted.
As a control primary cell, fibroblasts were isolated from a 3–4 month old male pig immediately postmortem. The exterior of one ear was thoroughly cleaned with 70% ethanol and ~1 cm2 of skin was excised along with underlying connective tissue using a sterile scalpel blade and placed in sterile PBS. Small pieces of subdermis were placed in 6 well tissue culture plates with 2 ml of growth medium per well and allowed to proliferate. Growth medium consisted of high glucose DMEM (Gibco-Invitrogen) supplemented with 10% FBS, 100 U/ml penicillin and 100 μg/ml streptomycin. Explants were removed within 3 days and the proliferating fibroblasts were allowed to reach confluency. Primary cultures were then processed for immunocytochemistry or RNA isolation as described below.
Alkaline phosphatase detection
PUC cells from various isolations and passage numbers were grown on glass coverslips or directly on 12 well tissue culture plates for 2–3 weeks. The medium was refreshed every 48 hours. Alkaline phosphatase activity was detected using an Alkaline Phosphatase Substrate Kit (Vector Laboratories, Burlingame, CA) according to the manufacturer's instructions. A blue reaction product following 20 minutes of exposure confirmed alkaline phosphatase activity. Specificity was verified by including 3 μM levamisole (an inhibitor of most forms of alkaline phosphatase) in the substrate solution prior to cell exposure. Cells were then fixed in 4% paraformaldehyde, mounted in DPX (Sigma-Aldrich, Inc.) and photographed using a Nikon CoolPix digital camera (Nikon, Melville, NY) or a QImaging Retiga 1300 digital CCD camera (Roper Industries, Duluth, GA). Images were processed for publication using CorelDRAW (version 10.0) and/or Paint Shop Pro (version 5.01, Corel Corporation, Ottawa, Ontario, Canada).
Hoechst dye exclusion and flow cytometry
Frozen PUC cells from four different donors (all between passage 5 and 10) were thawed and allowed to grow on 25 cm2 tissue culture flasks until colony formation occurred (1–2 weeks). PUC cells were dissociated in trypsin/EDTA, pelleted by centrifugation, resuspended at approximately 106 cells/ml in growth medium, and divided into two 1.5 ml microcentrifuge tubes (a small portion of each isolation was reserved for flow sorter calibration). Each tube was incubated with 2.5 μg/ml Hoechst 33342 (Sigma-Aldrich, Inc.) at 37°C with or without 50 μM verapamil (an inhibitor of multi-drug resistance proteins; Sigma-Aldrich, Inc.) for 90 minutes with intermittent mixing. After incubation, cells were pelleted and rinsed twice in ice-cold Hank's Balanced Salt Solution with 2% FBS (HBSS+FBS; Composition in mM: 137 NaCl; 5.4 KCl; 0.4 KH2PO4; 0.6 Na2HPO4; 5.5 glucose). Propidium iodide (Sigma-Aldrich, Inc.) was added at 2 μg/ml immediately prior to analysis to detect dead cells. Fluorescence detection was conducted on a FACSVantage SE flow cytometer (BD Biosciences, San Jose, CA) by counting 10,000–40,000 events. The dyes were excited using an ultra violet laser and fluorescence was measured using 485/22 and 660/20 dichroic bandpass filters. Experiments were performed two times with multiple observations in each run. In a separate experiment, cultured porcine fibroblasts were analyzed using the same protocol. Data were analyzed using WinMDI software (version 2.8; Scripps Research Institute, La Jolla, CA). Statistical analysis was conducted to evaluate the effect of verapamil on the percentage of cells with low dye uptake (Hoechstlow cells) using a t-test following log transformation of the data. The hypothesis was that verapamil would decrease the % of PUC cells that were Hoechstlow. A probability for a type I error of 0.05 (p = 0.05) was considered to be statistically significant.
RNA isolation, RT-PCR and quantitative RT-PCR
Total RNA was collected from PUC isolations after 1–3 weeks in culture, using an RNeasy Mini Kit (Qiagen, Valencia, CA). Briefly, PUC cells were exposed to a lysis buffer supplied with the kit and transferred to the RNeasy column. A DNase step (RNase-free DNase Set, Qiagen) was performed to remove genomic DNA. Following appropriate washings, RNA was eluted from the column in 20–30 μl nuclease-free water. RNA was also isolated from embryonic discs (day 14–15 postestrus, two isolates of 3 pooled discs) and cultured porcine fibroblasts (two isolates) using the same protocol. Expression of various stem cell markers was assessed using a OneStep RT-PCR kit (Qiagen) and gene specific primers. Primers for Sox-2 were designed based on highly homologous regions of human, mouse, bovine and/or sheep sequences (due to lack of porcine sequence at the time). Primers were designed using DNASTAR Primer Select (Macintosh version 4.0; DNASTAR, Inc., Madison, WI) or the web-based Primer3 program . These included Sox-2 (FWD: 5'-GCCTGGGCGCCGAGTGGA-3'; REV: 5'-GGGCGAGCCGTTCATGTAGGTCTG-3'; annealing temperature = 64°C, expected product length = 443 bp [Genbank: NM_003106]) and Nanog (FWD: 5'-ATCCAGCTTGTCCCCAAAG-3'; REV: 5'-ATTTCATTCGCTGGTTCTGG-3'; annealing temperature = 60°C, expected product length = 438 bp). The Nanog primers described in this report were designed based on new porcine sequence information (unpublished data) and encompassed a large segment homologous to the coding region of the human sequence. Primers for Oct-4 were synthesized using a published primer sequence  that was reported to span an intron (FWD: 5'-AGGTGTTCAGCCAAACGACC-3'; REV: 5'-TGATCGTTTGCCCTTCTGGC-3'; annealing temperature = 60°C). Product size was estimated to be 335 bp, (see ). β-actin primers were selected as a loading control (FWD: 5'-ATCTTGATCTTCATGGTGCTGGGC-3'; REV: 5'-ACCACTGGCATTGTCATGGACTCT-3'; annealing temperature = 60°C, expected product size = 545 bp) . The reactions were assembled using 200–800 ng of total RNA, 400 μM dNTPs, 400 nM FWD and REV primers, 1 μl enzyme mix and 5 μl buffer in a 25 μl reaction volume. The following PCR protocol was performed: 30 min reverse transcription step at 50–55°C, 15 min denature step at 95°C followed by 35 cycles of 94°C for 30 sec, annealing step for 30 sec and elongation at 72°C for 45 sec with a final extension at 72°C for 10 min using a Techne Touchgene thermocycler (Krackeler Scientific, Albany, NY). Reactions conducted without reverse transcriptase were run in parallel using ExTaq (TaKaRa, Otsu, Shiga, Japan) in place of the OneStep RT-PCR enzyme mix. PCR products were resolved in a 1% agarose gel containing 1 μg/ml ethidium bromide. Images were captured on a FluorChem 8900 imaging system (Alpha Innotech, San Leandro, CA) and processed for publication as described above.
Porcine embryonic disc, PUC cell, and porcine fibroblast RNA was collected as described above and subjected to quantitative RT-PCR using Nanog, Oct-4, Sox-2 and 18S ribosomal subunit primers (18S primer sequences were as follows: FWD: 5'-GAGGTTCGAAGACGATCAGA-3'; REV: 5'-TCGCTCCACCAACTAAGAAC-3'; annealing temperature = 55°C). In two separate experiments, RNA was collected from three pooled porcine embryonic discs (approximately 14 days postestrus), porcine fibroblasts from a single pig, and two different PUC cell isolations. In a third experiment, RNA was isolated from three pooled embryonic discs (approximately 14 days postestrus), porcine fibroblasts from a single pig and one PUC isolation, all of which were collected from different pigs than the first two experiments. RNA was quantified using an ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE) and diluted to nominally 10–200 ng/μl. Quantitative reactions were assembled using a Qiagen OneStep RT-PCR kit, 20, 200 or 800 ng of total RNA and 1× SYBR Green dye (Roche, Indianapolis, IN) in a 25 μl reaction volume. PCR was conducted for 50 cycles with SYBR Green fluorescence detected after each cycle. Reverse transcription was omitted as a negative control by replacing the Qiagen enzyme mix with ExTaq DNA polymerase (TaKaRa). All other parameters were identical to non-quantitative reactions (see protocol above). Reactions were carried out on a SmartCycler system (Cepheid, Sunnyvale, CA). For data analysis, the Ct value (the cycle number at which the fluorescence crosses the threshold) for each of the three markers was normalized to 18S to correct for minor variances in loading. The mRNA copy number relative to fibroblasts was calculated by raising 2 to the power of the difference of embryonic disc or PUC Ct value and fibroblast Ct value, providing a fold-difference to compare the relative expression levels.
Sequencing of PCR products was conducted by excising the bands from the agarose gel and purifying the complementary DNA (cDNA) using a QIAquick PCR purification kit (Qiagen). The purified cDNA was either sequenced at the Kansas State University DNA Sequencing Facility, or further processed for sequencing on a CEQ 8000 DNA sequencer (Beckman Coulter, Fullerton, CA). Briefly, purified cDNA was resolved by gel electrophoresis, prepared for analysis using a dye terminator cycle sequencing kit (DTCS, Beckman Coulter), precipitated and suspended in an appropriate sequencing buffer. The resulting sequences were analyzed and aligned using the Basic Local Alignment Sequence Tool (BLAST) either to known GenBank gene entries or to the porcine database in The Institute for Genomic Research (TIGR). Alignment figures were created using BOXHADE 3.21 http://www.ch.embnet.org/software/BOX_form.html.
PUC cells were seeded onto glass coverslips and allowed to grow for up to 2 weeks. Porcine fibroblasts were similarly seeded and cultured for up to 7 days prior to analysis. Growth medium was removed and the cells were fixed in 4% paraformaldehyde for 5 min followed by permeation with 0.2% Triton-X-100 (Fisher Chemicals; Fairlawn, NJ) and blocked with an appropriate agent (3% normal goat or donkey serum + 1% bovine serum albumin in PBS). The primary antibodies used were goat anti-Oct-3/4 (Santa Cruz Biotechnology; Santa Cruz, CA; n = 3) diluted 1:50 or 1:100 in 0.5× blocking solution, or rabbit anti-Nanog (Chemicon International; Temecula, CA; n = 5) diluted 1:200 and applied for 1 hr at room temperature or overnight at 4°C. Secondary antibodies (donkey anti-goat IgG-FITC conjugated, diluted 1:200 in PBS (Jackson ImmunoResearch Laboratories, West Grove, PA) or goat anti-rabbit IgG-Alexa-488 conjugated, diluted 1:500 in PBS (Molecular Probes, Eugene, OR)) were applied for 1 hour at room temperature. Cells were further counterstained with 4',6-diamidino-2-phenylindole (DAPI, Vector Laboratories, Burlingame, CA) and imaged on a Nikon Eclipse 80i microscope fitted with a Photometrics CoolSnap ES digital camera using appropriate filters. Images were captured with MetaMorph software (Molecular Devices Corporation, Sunnyvale, CA) and processed for publication using CorelDRAW and/or Paint Shop Pro with identical settings for control and experimental slides.
Morphological assessment and selection
Alkaline phosphatase detection
Hoechst dye-exclusion and flow cytometry
RT-PCR detection and sequence analysis
Expression of the three transcription factors was also detected in porcine fibroblasts that were isolated from a 3–4 month old pig (Fig. 5C). The multiple bands observed in the Sox-2 lane in Fig. 5C were observed in 5 of 22 reactions using fibroblasts.
The sequence of Sox-2 PCR products employing RNA isolated from PUC cells displayed 96% (388/401 bp) homology to the human sequence [Genbank: NM_003106] and 97% (392/401 bp) homology to the ovine sequence [GenBank: X96997] [see Additional file 2]. Analysis also revealed >99% (400/401 bp) homology to a porcine EST [TIGR: TC208722]. Nanog primers produced a single amplified product of expected size from PUC isolations with 86% (326/379 bp) homology to a human Nanog sequence [Genbank: AB093576] and a 268 bp segment with 99% homology to the published Sus scrofa Nanog partial sequence [GenBank: AY596464] [see Additional file 1]. Oct-4 PCR amplified products from PUC isolations displayed >99% (298/300) homology to the Sus scrofa Oct-4 sequence [TIGR: TC205936] [see Additional file 3].
Here we report expression of Nanog, Oct-4 and Sox-2 in cultured PUC matrix cells. These transcription factors are considered key regulators of gene transcription in primitive stem cells. Quantitative RT-PCR revealed that PUC cells and porcine embryonic discs express Nanog RNA at higher levels than porcine fibroblasts. Both Oct-4 and Sox-2 message was present in discs in substantially greater amounts than in PUC cells, and PUC cells contained more message than fibroblasts. Nanog, Oct-4, and Sox-2 have been reported to occupy the promoters of at least 2,260 human genes and these transcription factors co-occupy 353 gene promoters . Thus, these transcription factors regulate pluripotency and self renewal both jointly and individually in human ESCs. Similar data are not available for the pig, but it is likely that these transcription factors regulate central events in stem cell renewal and potency in this species.
We observed gene expression of RNA for all three transcription factors in porcine embryonic discs, PUC cells, and fibroblasts. Therefore, quantitative RT-PCR data on the expression of these transcription factors was undertaken. In particular, the high level of mRNA expression of Nanog in both PUC cells and embryonic discs suggests that the regulatory pathways influenced by Nanog in the pig may be similarly activated or inactivated in the embryonic disc and PUC cells. However, the reduced expression of Oct-4 and Sox-2 in PUC cells relative to the embryonic disc could indicate that genes regulated by these transcription factors may have different expression patterns in these two tissues. Because genetic studies of the functions of these transcription factors are not available in the pig, the meaning of the lower expression of Oct-4 and Sox-2 mRNA in PUC cells is unknown. The significance of expression, albeit at low levels, of all three transcription factors in fibroblasts is also unclear but may indicate that quantitative regulation is determinative of the differentiation state in this species.
A recent paper described colony formation and Oct-4 expression in fetal murine and porcine fibroblasts, but failed to replicate these findings in adult-derived porcine fibroblasts . Expression of Oct-4 in fetal fibroblasts was only detected when the cells were maintained in 30% calf serum, suggesting that some constituent of the serum must be present in sufficient quantities for expression to be seen. The growth medium used in the present study contains only 2% FBS, although it is supplemented with several other factors, including EGF and dexamethasone. These differences in culture conditions may explain the divergent results. Other differences in early gene expression between the pig and the mouse have also been noted. For example, Oct-4 is expressed in trophectoderm as well as in the inner cell mass of the pig, but only the latter in the mouse . Other reports have suggested that Nanog RNA is present in both the embryonic and extraembryonic porcine conceptus tissues at day 15 of pregnancy .
The relative levels of mRNA expression for Nanog, Oct-4 and Sox-2 (as compared to fibroblasts) appears to vary in embryonic discs and PUC cells with embryonic discs clearly expressing more Oct-4 and Sox-2. Numerous factors may explain these results. First, PUC cells and fibroblasts may contain stem cells with similar gene expression levels to those present in embryonic discs, but have a smaller stem cell to non-stem cell ratio than embryonic discs. However, immunocytochemical analysis suggests that while protein levels may differ in PUC cells and fibroblasts, both cell types display nuclear labeling in a uniform manner suggesting that all cells express (or do not express) Nanog and Oct-4 protein at similar levels. Alternatively, posttranslational modifications may account for the reduced expression of Nanog protein and lack of Oct-4 protein in porcine fibroblasts despite the detection of mRNA for both genes. It is unknown whether no protein or an alternative form of the protein is being expressed in fibroblasts. Nonetheless, PUC cells express Nanog, Sox-2 and Oct-4 at the mRNA level with nuclear immunoreactivity for Nanog and Oct-4 being clearly and uniformly present.
The expression of Nanog, Oct-4 and Sox-2 was detected by RT-PCR in PUC cells. The amplification of these transcription factors using RT-PCR techniques produced bands of expected sizes for each PCR product. The subsequent sequencing of the product and high homology to published human and pig sequences is a strong indication of the presence of these genes. Three separate quantitative analysis experiments revealed higher mRNA expression levels of Nanog and Sox-2 in PUC cells compared to fibroblasts, while two out of three experiments revealed higher levels of Oct-4 mRNA in PUC cells compared to fibroblasts. Nuclear immunocytochemical labeling for Oct-4 and Nanog support this result. Recent studies have identified several processed pseudogenes for Nanog and Oct-4 in the human and mouse genome, including two that have been identified in expressed sequence tags [33, 34]. It is currently unknown whether similar pseudogenes exist in pigs and whether they are expressed. However, nuclear immunolabeling suggests the presence of functional Nanog and Oct-4 protein in PUC cells.
Oct-4, Nanog and Sox-2 are central regulators for maintaining a pluripotent state in mouse and human ESCs. In the mouse, artificial Oct-4 upregulation results in differentiation of ESCs into extraembryonic mesoderm or endoderm while Oct-4 knockout ESCs differentiate into trophectoderm [35, 36]. Upregulation of Nanog allows mouse ESCs to remain pluripotent without the need for leukemia inhibitory factor (LIF) supplementation in the growth medium [7, 8]. Sox-2 is a regulatory transcription factor expressed in early development in many tissues including ESCs . Gene expression was supported by immunocytochemical detection of a Nanog epitope that demonstrated nuclear labeling, consistent with transcription factor localization. Oct-4 immunoreactivity in the nucleus was also detected. In sum, these data suggest that PUC matrix cells constitute a population of stem cells that share some of the phenotypic characteristics of ESCs and also of non-embryonic stem cell populations.
Alkaline phosphatase activity was observed in colony-forming PUC isolations. Alkaline phosphatase is an enzyme long-known to be expressed in ESCs as well as primordial germ cells . The reaction product formed in PUC cell cultures is most intense in and around the colonies, similar to the pattern observed in ESC cultures and other colony-forming stem cells. Alkaline phosphatase is an enzyme expressed in many tissues and alone is not specific for stem cells. However, during development, primordial germ cells (which express alkaline phosphatase) are formed in the yolk sac and migrate through the developing umbilical cord en route to their final destination in the gonadal ridge. It is possible that some of these migrating germ cells or their descendents remain in the umbilical cord matrix.
PUC cells displayed a Hoeschtlow side population that was detected by flow cytometry. Hematopoietic stem cells contain a small population of Hoechst dye-excluding cells (termed side population or SP) when examined by flow cytometry, and this property is inhibited in the presence of verapamil [38, 39]. Although verapamil is best known as a calcium channel blocker, it is also used as an inhibitor of P-glycoprotein, a member of the ATP-binding cassette (ABC) transporter superfamily, which is found in hematopoietic stem cells as well as cancer cells . These side population cells exhibit the greatest hematopoietic stem cell activity in repopulation studies . Typically, the percentage of Hoechstlow cells in bone marrow samples is less than 1% of the total population. Our observation of approximately 7% (of which, 3% were verapamil sensitive) suggests that a higher concentration of stem-like cells are present in PUC cell isolations.
The present results are consistent with the interpretation that PUC cells represent a stem cell population that expresses the central regulators required for mouse embryonic stem cells. Transplantation studies will be required to define the potential of PUC cells when placed in various in vivo environments, but the characteristics identified here suggest that PUC cells will have a wide potential.
We conclude that PUC matrix cells contain unique and primitive cells whose potential is as yet undefined. Ease of collection and propagation, and abundant numbers make PUC matrix cells an attractive candidate as a resource for stem cell biotechnology and biomedical research.
The authors extend their thanks to Justin Voge and Douglas Eborn for assistance in PCR supplies and design, Theresa Rathbun for assistance with tissue acquisition and Marla Pyle, Rebecca Quesnell, Julie Hix, Dr. Miriam Burton and Dr. Fernando Pierucci-Alves for technical assistance. We also extend thanks to Tammy Koopman for assistance with flow cytometry data acquisition and analysis. This work represents contribution # 06-98-J from the Kansas Agricultural Experiment Station, and utilized the COBRE Molecular Core Facility (NIH P20 PR017686).
- Donovan PJ, Gearhart J: The end of the beginning for pluripotent stem cells. Nature. 2001, 414 (6859): 92-97. 10.1038/35102154.View ArticlePubMedGoogle Scholar
- Cai J, Weiss ML, Rao MS: In search of "stemness". Exp Hematol. 2004, 32 (7): 585-598. 10.1016/j.exphem.2004.03.013.PubMed CentralView ArticlePubMedGoogle Scholar
- Rosner MH, Vigano MA, Ozato K, Timmons PM, Poirier F, Rigby PW, Staudt LM: A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature. 1990, 345 (6277): 686-692. 10.1038/345686a0.View ArticlePubMedGoogle Scholar
- Scholer HR, Dressler GR, Balling R, Rohdewohld H, Gruss P: Oct-4: a germline-specific transcription factor mapping to the mouse t-complex. Embo J. 1990, 9 (7): 2185-2195.PubMed CentralPubMedGoogle Scholar
- Scholer HR, Ruppert S, Suzuki N, Chowdhury K, Gruss P: New type of POU domain in germ line-specific protein Oct-4. Nature. 1990, 344 (6265): 435-439. 10.1038/344435a0.View ArticlePubMedGoogle Scholar
- Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, Lovell-Badge R: Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 2003, 17 (1): 126-140. 10.1101/gad.224503.PubMed CentralView ArticlePubMedGoogle Scholar
- Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S, Smith A: Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell. 2003, 113 (5): 643-655. 10.1016/S0092-8674(03)00392-1.View ArticlePubMedGoogle Scholar
- Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, Maruyama M, Maeda M, Yamanaka S: The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell. 2003, 113 (5): 631-642. 10.1016/S0092-8674(03)00393-3.View ArticlePubMedGoogle Scholar
- Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG, Gifford DK, Melton DA, Jaenisch R, Young RA: Core transcriptional regulatory circuitry in human embryonic stem cells. Cell. 2005, 122 (6): 947-956. 10.1016/j.cell.2005.08.020.PubMed CentralView ArticlePubMedGoogle Scholar
- Kucia M, Reca R, Jala VR, Dawn B, Ratajczak J, Ratajczak MZ: Bone marrow as a home of heterogenous populations of nonhematopoietic stem cells. Leukemia. 2005, 19 (7): 1118-1127. 10.1038/sj.leu.2403796.View ArticlePubMedGoogle Scholar
- Erices A, Conget P, Minguell JJ: Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 2000, 109 (1): 235-242. 10.1046/j.1365-2141.2000.01986.x.View ArticlePubMedGoogle Scholar
- Bodger MP: Isolation of hemopoietic progenitor cells from human umbilical cord blood. Exp Hematol. 1987, 15 (8): 869-876.PubMedGoogle Scholar
- Yang SE, Ha CW, Jung M, Jin HJ, Lee M, Song H, Choi S, Oh W, Yang YS: Mesenchymal stem/progenitor cells developed in cultures from UC blood. Cytotherapy. 2004, 6 (5): 476-486. 10.1080/14653240410005041.View ArticlePubMedGoogle Scholar
- Sarugaser R, Lickorish D, Baksh D, Hosseini MM, Davies JE: Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells. 2005, 23 (2): 220-229. 10.1634/stemcells.2004-0166.View ArticlePubMedGoogle Scholar
- Kim JW, Kim SY, Park SY, Kim YM, Kim JM, Lee MH, Ryu HM: Mesenchymal progenitor cells in the human umbilical cord. Ann Hematol. 2004, 83 (12): 733-738. 10.1007/s00277-004-0918-z.View ArticlePubMedGoogle Scholar
- Romanov YA, Svintsitskaya VA, Smirnov VN: Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells. 2003, 21 (1): 105-110. 10.1634/stemcells.21-1-105.View ArticlePubMedGoogle Scholar
- Yen BL, Huang HI, Chien CC, Jui HY, Ko BS, Yao M, Shun CT, Yen ML, Lee MC, Chen YC: Isolation of multipotent cells from human term placenta. Stem Cells. 2005, 23 (1): 3-9. 10.1634/stemcells.2004-0098.View ArticlePubMedGoogle Scholar
- Fukuchi Y, Nakajima H, Sugiyama D, Hirose I, Kitamura T, Tsuji K: Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells. 2004, 22 (5): 649-658. 10.1634/stemcells.22-5-649.View ArticlePubMedGoogle Scholar
- Tsai MS, Lee JL, Chang YJ, Hwang SM: Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod. 2004, 19 (6): 1450-1456. 10.1093/humrep/deh279.View ArticlePubMedGoogle Scholar
- Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH: Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001, 7 (2): 211-228. 10.1089/107632701300062859.View ArticlePubMedGoogle Scholar
- Toma JG, Akhavan M, Fernandes KJ, Barnabe-Heider F, Sadikot A, Kaplan DR, Miller FD: Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol. 2001, 3 (9): 778-784. 10.1038/ncb0901-778.View ArticlePubMedGoogle Scholar
- Prelle K, Vassiliev IM, Vassilieva SG, Wolf E, Wobus AM: Establishment of pluripotent cell lines from vertebrate species--present status and future prospects. Cells Tissues Organs. 1999, 165 (3-4): 220-236. 10.1159/000016683.View ArticlePubMedGoogle Scholar
- Fu YS, Shih YT, Cheng YC, Min MY: Transformation of human umbilical mesenchymal cells into neurons in vitro. J Biomed Sci. 2004, 11 (5): 652-660.View ArticlePubMedGoogle Scholar
- Mitchell KE, Weiss ML, Mitchell BM, Martin P, Davis D, Morales L, Helwig B, Beerenstrauch M, Abou-Easa K, Hildreth T, Troyer D, Medicetty S: Matrix cells from Wharton's jelly form neurons and glia. Stem Cells. 2003, 21 (1): 50-60.View ArticlePubMedGoogle Scholar
- Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, Guo YJ, Fu YS, Lai MC, Chen CC: Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells. 2004, 22 (7): 1330-1337. 10.1634/stemcells.2004-0013.View ArticlePubMedGoogle Scholar
- Yang LY, Zheng JK, Wang CY, Xu MD: [Stromal cells from human Wharton's jelly differentiate into neural cells]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2005, 36 (1): 13-16.PubMedGoogle Scholar
- Bucher P, Morel P, Buhler LH: Xenotransplantation: an update on recent progress and future perspectives. Transpl Int. 2005, 18 (8): 894-901. 10.1111/j.1432-2277.2005.00124.x.View ArticlePubMedGoogle Scholar
- Rozen S, Skaletsky H: Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol. 2000, 132: 365-386.PubMedGoogle Scholar
- Kues WA, Petersen B, Mysegades W, Carnwath JW, Niemann H: Isolation of murine and porcine fetal stem cells from somatic tissue. Biol Reprod. 2005, 72 (4): 1020-1028. 10.1095/biolreprod.104.031229.View ArticlePubMedGoogle Scholar
- Yelich JV, Pomp D, Geisert RD: Ontogeny of elongation and gene expression in the early developing porcine conceptus. Biol Reprod. 1997, 57 (5): 1256-1265. 10.1095/biolreprod57.5.1256.View ArticlePubMedGoogle Scholar
- Kirchhof N, Carnwath JW, Lemme E, Anastassiadis K, Scholer H, Niemann H: Expression pattern of Oct-4 in preimplantation embryos of different species. Biol Reprod. 2000, 63 (6): 1698-1705. 10.1095/biolreprod63.6.1698.View ArticlePubMedGoogle Scholar
- Voge JL EDRGDMDDL: Tentative identification of nanog expression in the pig conceptus [abstract]. Seventh International Conference on Pig Reproduction. 2005, Kansas State Univeristy, 96-Google Scholar
- Booth HA, Holland PW: Eleven daughters of NANOG. Genomics. 2004, 84 (2): 229-238. 10.1016/j.ygeno.2004.02.014.View ArticlePubMedGoogle Scholar
- Pain D, Chirn GW, Strassel C, Kemp DM: Multiple retropseudogenes from pluripotent cell-specific gene expression indicates a potential signature for novel gene identification. J Biol Chem. 2005, 280 (8): 6265-6268. 10.1074/jbc.C400587200.View ArticlePubMedGoogle Scholar
- Niwa H, Miyazaki J, Smith AG: Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet. 2000, 24 (4): 372-376. 10.1038/74199.View ArticlePubMedGoogle Scholar
- Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, Chambers I, Scholer H, Smith A: Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell. 1998, 95 (3): 379-391. 10.1016/S0092-8674(00)81769-9.View ArticlePubMedGoogle Scholar
- MacGregor GR, Zambrowicz BP, Soriano P: Tissue non-specific alkaline phosphatase is expressed in both embryonic and extraembryonic lineages during mouse embryogenesis but is not required for migration of primordial germ cells. Development. 1995, 121 (5): 1487-1496.PubMedGoogle Scholar
- Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC: Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med. 1996, 183 (4): 1797-1806. 10.1084/jem.183.4.1797.View ArticlePubMedGoogle Scholar
- Bellamy WT: P-glycoproteins and multidrug resistance. Annu Rev Pharmacol Toxicol. 1996, 36: 161-183. 10.1146/annurev.pa.36.040196.001113.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.